tiprankstipranks
Trending News
More News >
Athira Pharma (ATHA)
NASDAQ:ATHA
US Market

Athira Pharma (ATHA) Income Statement

Compare
569 Followers

Athira Pharma Income Statement

Last quarter (Q3 2025), Athira Pharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Athira Pharma's net income was $-6.61M. See Athira Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ -479.00K$ -2.00M
Operating Expenses
$ 100.90M$ 125.47M$ 104.02M$ 63.54M$ 18.00M
Depreciation and Amortization
$ 970.00K$ 969.00K$ 845.00K$ 479.00K$ 2.00K
EBITDA
$ -95.81M$ -125.97M$ -88.01M$ -54.37M$ -19.59M
Operating Income
$ -100.90M$ -125.47M$ -104.02M$ -64.02M$ -20.00M
Other Income/Expenses
$ 3.96M$ 7.79M$ 8.38M$ 9.17M$ 40.00K
Pretax Income
$ -96.94M$ -117.67M$ -95.64M$ -54.85M$ -19.95M
Net Income
$ -96.94M$ -117.67M$ -95.64M$ -54.85M$ -19.95M
Per Share Metrics
Basic EPS
$ -25.20$ -30.90$ -25.30$ -14.90$ -6.10
Diluted EPS
$ -25.20$ -30.90$ -25.30$ -14.90$ -6.10
Weighted Average Shares Outstanding
3.85M 3.80M 3.77M 3.69M 3.25M
Weighted Average Shares Outstanding (Diluted)
3.85M 3.80M 3.77M 3.69M 3.25M
Currency in USD

Athira Pharma Earnings and Revenue History